Weight gain secondary to the use of oral Janus kinase inhibitors: A systematic review and meta-analysis

Oral Janus kinase inhibitors (JAKi) are increasingly used in dermatology, rheumatology, gastroenterology, and hematology. While effective, they can cause adverse effects such as acne, nausea, cytopenia, dyslipidemia, and Herpes zoster. Recent reports have linked JAKi usage to weight changes, particu...

Description complète

Détails bibliographiques

Auteurs principaux:	Grace Xiong, BHSc, Eric Yu, Martin Heung, Jaehyeong Yang, BSc, Megan Lowe, MPH, Mohannad Abu-Hilal, MD
Format:	Artigo
Langue:	Inglês
Publié:	Elsevier 2025-04-01
Collection:	JAAD International
Sujets:	abrocitinib baricitinib Janus kinase inhibitors medical dermatology ruxolitinib tofacitinib
Accès en ligne:	http://www.sciencedirect.com/science/article/pii/S2666328724001871
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!